Goodrx Holdings 

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$195,251
$200,610
$197,880
$196,644
Gross Profit
183,567
171,775
169,470
139,138
EBITDA
38,002
36,843
36,323
34,876
EBIT
20,467
19,878
20,381
-9,814
Net Income
12,259
6,694
-1,008
-25,869
Net Change In Cash
195,251
200,610
197,880
196,644
Free Cash Flow
123,628
-7,528
21,971
2,996
Cash
423,777
524,903
533,294
672,296
Basic Shares
388,504
384,732
390,048
403,248

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$750,265
$766,554
$745,424
$550,700
Gross Profit
683,340
701,475
698,708
521,113
EBITDA
108,824
68,538
48,004
-257,107
EBIT
1,156
11,012
10,363
-280,015
Net Income
-8,868
-32,828
-25,254
-293,623
Net Change In Cash
750,265
766,554
745,424
550,700
Cost of Revenue
-183,944
-30,482
945,541
Free Cash Flow
82,526
91,566
144,322
95,517
Cash
672,296
757,165
941,109
968,691
Basic Shares
410,315
412,858
400,562
391,660

Earnings Calls

Quarter EPS
2024-09-30
$0.08
2024-06-30
$0.08
2024-03-31
$0.08
2023-12-31
$0.08